Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19
Thomas G. Stewart(University of North Carolina at Chapel Hill), Heather Heavlin(Institute of Accelerating Systems and Applications), George J. Hanna(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carolyn T. Bramante(University of Minnesota), Stacey J. Adam(Foundation for the National Institutes of Health), Adrian F. Hernandez(Duke University), Tiffany Schwasinger‐Schmidt(University of Kansas), John Williamson(Institute of Accelerating Systems and Applications), Florence Thicklin, G. Michael Felker(Clinical Research Institute), Elizabeth Shenkman(University of Florida), David R. Boulware(University of Minnesota Medical Center), Paulina A. Rebolledo(Emory University), Adit A. Ginde(University of Colorado Anschutz Medical Campus), Mario Castro(University of Kansas Medical Center), Sarah E. Dunsmore(National Center for Advancing Translational Sciences), Alicia Herbert(Institute of Accelerating Systems and Applications), Leslie Lenert(Medical University of South Carolina), Jennifer Jackman(Institute of Accelerating Systems and Applications), Erin Nowell(Institute of Accelerating Systems and Applications), Susanna Naggie(Duke University), Russell L. Rothman(Vanderbilt University Medical Center), Mark Sulkowski(Johns Hopkins University), Allison DeLong(Institute of Accelerating Systems and Applications), Sean P. Collins(Wayne State University), Matthew W. McCarthy(Cornell University), Orlando Quintero(Stanford University), Kathleen M. McTigue(University of Pittsburgh), Rhonda Wilder(Duke University), Ahmad Mourad, Dushyantha Jayaweera(University of Miami), Nina Gentile(Temple University), Samantha Dockery(Institute of Accelerating Systems and Applications), M. Patricia McAdams(Institute of Accelerating Systems and Applications), Julia Vail(Institute of Accelerating Systems and Applications), Kayla Korzekwinski(Institute of Accelerating Systems and Applications), Martina Oyelakin(Institute of Accelerating Systems and Applications), Julie Chopp(Institute of Accelerating Systems and Applications), Stephen C. Lim(University Medical Center New Orleans), Ryan Fraser(Institute of Accelerating Systems and Applications), Rodney H. Adkins, Kadie Wells(Institute of Accelerating Systems and Applications), Idania T. Garcia del Sol(Miami VA Healthcare System), Mark F. Ward(Institute of Accelerating Systems and Applications), Mathew Crow(Institute of Accelerating Systems and Applications), Desmon Randle(Institute of Accelerating Systems and Applications), Allegra Stone(Institute of Accelerating Systems and Applications), Jake Scott(Stanford University), Christopher J. Lindsell(Clinical Research Institute)
Cited by 31
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
|New England Journal of Medicine|2018|1.9k